Cytosorbents (CTSO) has issued an update.
CytoSorbents Corporation has successfully met Nasdaq’s minimum bid price requirement, ensuring its continued listing on the market. The company’s stock maintained a closing price of at least $1.00 for over ten consecutive days, rectifying the previous non-compliance issue where the stock had fallen below this threshold. With this achievement, CytoSorbents has received official confirmation from Nasdaq that it has regained compliance, and the matter is now considered closed.
For a thorough assessment of CTSO stock, go to TipRanks’ Stock Analysis page.
